Industry: Medical Devices & Consumables
Published Date: 2026-07-10
Pages: 124 Pages
Report ld: 5534838
Request Sample
Customized Report
Veno-Arterial ECMO System Market Size(US$)

CAGR 2026-2032
3.1%
Market Size,2032
USD 343
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Veno-Arterial ECMO System market was valued at US$ 278 million in 2025 and is anticipated to reach US$ 343 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Veno-Arterial ECMO System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2025, global Veno-Arterial Extracorporeal ECMO Systems production reached approximately 993 units, the average price is 280 k usd/unit. This report studies the Veno-Arterial ECMO System market. Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. Veno-Arterial ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since Veno-Arterial ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Market Concentration and Major Players:
Internationally, the market concentration of venous-arterial ECMO systems is relatively high, mainly concentrated in developed European countries. Large manufacturers include Medtronic and Terumo. Domestically, however, the venous-arterial ECMO system market still has significant room for growth.
Manufacturing Process and Market Trends:
The core of the manufacturing process for venous-arterial ECMO systems lies in the integrated design of the blood pump and membrane oxygenator. Centrifugal pumps are typically used instead of earlier roller pumps to reduce the risk of hemolysis. The membrane lung is often made of polymethylpentene hollow fiber braiding to achieve efficient gas exchange. All tubing requires heparin or phosphorylcholine coating to reduce coagulation activation during extracorporeal circulation. The cannula is matched with different stiffness and lengths depending on the femoral artery/venous or central vascular pathway. The entire system must be assembled in a sterile environment and undergo pre-filling and leak testing.
In terms of global market trends, VA-ECMO, due to the essential need for cardiogenic shock and postoperative circulatory support, is extending from traditional intensive care ICUs to mobile transport and hybrid surgical scenarios. This is driving manufacturers to make the main unit smaller, the intubation faster, and the anticoagulant coating longer-lasting. At the same time, the long-lasting effect of membrane lungs and the simplification of percutaneous cannulation have become the focus of iteration. In Europe and the United States, Macowell and Medtronic still dominate, but local companies in China, India and other regions have entered the low-end and emergency procurement markets with their cost and registration speed. The overall pattern is shifting from oligopoly to tiered competition. In the long run, remote monitoring and consumable subscription models will further reshape the aftermarket.
This report delivers a comprehensive overview of the global Veno-Arterial ECMO System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Veno-Arterial ECMO System. The Veno-Arterial ECMO System market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Veno-Arterial ECMO System market comprehensively. Regional market sizes by Structure, by Application, by Integrated, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Veno-Arterial ECMO System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Structure, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Structure, by Application, by Integrated, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Veno-Arterial ECMO System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Veno-Arterial ECMO System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Structure, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Veno-Arterial ECMO System Market Overview
1.1 Product Definition
1.2 Veno-Arterial ECMO System by Structure
1.2.1 Global Veno-Arterial ECMO System Market Value by Structure: 2025 vs 2032
1.2.2 Portable Veno-Arterial ECMO System
1.2.3 Fixed Veno-Arterial ECMO System
1.3 Veno-Arterial ECMO System by Integrated
1.3.1 Global Veno-Arterial ECMO System Market Value by Integrated: 2025 vs 2032
1.3.2 Modular
1.3.3 Integrated
1.4 Veno-Arterial ECMO System by Pump
1.4.1 Global Veno-Arterial ECMO System Market Value by Pump: 2025 vs 2032
1.4.2 Centrifugal Pump
1.4.3 Roller Pump
1.5 Veno-Arterial ECMO System by Application
1.5.1 Global Veno-Arterial ECMO System Market Value by Application: 2025 vs 2032
1.5.2 Neonatal
1.5.3 Pediatric
1.5.4 Adult
1.6 Global Veno-Arterial ECMO System Market Size Estimates and Forecasts
1.6.1 Global Veno-Arterial ECMO System Revenue 2021–2032
1.6.2 Global Veno-Arterial ECMO System Sales 2021–2032
1.6.3 Global Veno-Arterial ECMO System Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Veno-Arterial ECMO System Market Competition by Manufacturers
2.1 Global Veno-Arterial ECMO System Sales Market Share by Manufacturers (2021–2026)
2.2 Global Veno-Arterial ECMO System Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Veno-Arterial ECMO System Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Veno-Arterial ECMO System, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Veno-Arterial ECMO System, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Veno-Arterial ECMO System, Product Types and Applications
2.7 Global Key Manufacturers of Veno-Arterial ECMO System, Date of Entry into the Industry
2.8 Global Veno-Arterial ECMO System Market Competitive Situation and Trends
2.8.1 Global Veno-Arterial ECMO System Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Veno-Arterial ECMO System Players Market Share by Revenue
2.8.3 Global Veno-Arterial ECMO System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veno-Arterial ECMO System Market Scenario by Region
3.1 Global Veno-Arterial ECMO System Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Veno-Arterial ECMO System Sales by Region: 2021–2032
3.2.1 Global Veno-Arterial ECMO System Sales by Region: 2021–2026
3.2.2 Global Veno-Arterial ECMO System Sales by Region: 2027–2032
3.3 Global Veno-Arterial ECMO System Revenue by Region: 2021–2032
3.3.1 Global Veno-Arterial ECMO System Revenue by Region: 2021–2026
3.3.2 Global Veno-Arterial ECMO System Revenue by Region: 2027–2032
3.4 North America Veno-Arterial ECMO System Market Facts & Figures by Country
3.4.1 North America Veno-Arterial ECMO System Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Veno-Arterial ECMO System Sales by Country (2021–2032)
3.4.3 North America Veno-Arterial ECMO System Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veno-Arterial ECMO System Market Facts & Figures by Country
3.5.1 Europe Veno-Arterial ECMO System Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Veno-Arterial ECMO System Sales by Country (2021–2032)
3.5.3 Europe Veno-Arterial ECMO System Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.6 Asia Pacific Veno-Arterial ECMO System Market Facts & Figures by Region
3.6.1 Asia Pacific Veno-Arterial ECMO System Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Veno-Arterial ECMO System Sales by Region (2021–2032)
3.6.3 Asia Pacific Veno-Arterial ECMO System Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.7 Latin America Veno-Arterial ECMO System Market Facts & Figures by Country
3.7.1 Latin America Veno-Arterial ECMO System Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Veno-Arterial ECMO System Sales by Country (2021–2032)
3.7.3 Latin America Veno-Arterial ECMO System Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.8 Middle East and Africa Veno-Arterial ECMO System Market Facts & Figures by Country
3.8.1 Middle East and Africa Veno-Arterial ECMO System Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Veno-Arterial ECMO System Sales by Country (2021–2032)
3.8.3 Middle East and Africa Veno-Arterial ECMO System Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Structure
4.1 Global Veno-Arterial ECMO System Sales by Structure (2021–2032)
4.1.1 Global Veno-Arterial ECMO System Sales by Structure (2021–2026)
4.1.2 Global Veno-Arterial ECMO System Sales by Structure (2027–2032)
4.1.3 Global Veno-Arterial ECMO System Sales Market Share by Structure (2021–2032)
4.2 Global Veno-Arterial ECMO System Revenue by Structure (2021–2032)
4.2.1 Global Veno-Arterial ECMO System Revenue by Structure (2021–2026)
4.2.2 Global Veno-Arterial ECMO System Revenue by Structure (2027–2032)
4.2.3 Global Veno-Arterial ECMO System Revenue Market Share by Structure (2021–2032)
4.3 Global Veno-Arterial ECMO System Price by Structure (2021–2032)
5 Segment by Application
5.1 Global Veno-Arterial ECMO System Sales by Application (2021–2032)
5.1.1 Global Veno-Arterial ECMO System Sales by Application (2021–2026)
5.1.2 Global Veno-Arterial ECMO System Sales by Application (2027–2032)
5.1.3 Global Veno-Arterial ECMO System Sales Market Share by Application (2021–2032)
5.2 Global Veno-Arterial ECMO System Revenue by Application (2021–2032)
5.2.1 Global Veno-Arterial ECMO System Revenue by Application (2021–2026)
5.2.2 Global Veno-Arterial ECMO System Revenue by Application (2027–2032)
5.2.3 Global Veno-Arterial ECMO System Revenue Market Share by Application (2021–2032)
5.3 Global Veno-Arterial ECMO System Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic (Ireland)
6.1.1 Medtronic (Ireland) Company Information
6.1.2 Medtronic (Ireland) Description and Business Overview
6.1.3 Medtronic (Ireland) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic (Ireland) Veno-Arterial ECMO System Product Portfolio
6.1.5 Medtronic (Ireland) Recent Developments/Updates
6.2 Getinge (Sweden)
6.2.1 Getinge (Sweden) Company Information
6.2.2 Getinge (Sweden) Description and Business Overview
6.2.3 Getinge (Sweden) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Getinge (Sweden) Veno-Arterial ECMO System Product Portfolio
6.2.5 Getinge (Sweden) Recent Developments/Updates
6.3 Terumo (Japan)
6.3.1 Terumo (Japan) Company Information
6.3.2 Terumo (Japan) Description and Business Overview
6.3.3 Terumo (Japan) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Terumo (Japan) Veno-Arterial ECMO System Product Portfolio
6.3.5 Terumo (Japan) Recent Developments/Updates
6.4 Fresenius Medical Care (Germany)
6.4.1 Fresenius Medical Care (Germany) Company Information
6.4.2 Fresenius Medical Care (Germany) Description and Business Overview
6.4.3 Fresenius Medical Care (Germany) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Fresenius Medical Care (Germany) Veno-Arterial ECMO System Product Portfolio
6.4.5 Fresenius Medical Care (Germany) Recent Developments/Updates
6.5 Eurosets S.r.l. (Italy)
6.5.1 Eurosets S.r.l. (Italy) Company Information
6.5.2 Eurosets S.r.l. (Italy) Description and Business Overview
6.5.3 Eurosets S.r.l. (Italy) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Eurosets S.r.l. (Italy) Veno-Arterial ECMO System Product Portfolio
6.5.5 Eurosets S.r.l. (Italy) Recent Developments/Updates
6.6 Abbott Laboratories (USA)
6.6.1 Abbott Laboratories (USA) Company Information
6.6.2 Abbott Laboratories (USA) Description and Business Overview
6.6.3 Abbott Laboratories (USA) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Abbott Laboratories (USA) Veno-Arterial ECMO System Product Portfolio
6.6.5 Abbott Laboratories (USA) Recent Developments/Updates
6.7 LivaNova PLC (UK)
6.7.1 LivaNova PLC (UK) Company Information
6.7.2 LivaNova PLC (UK) Description and Business Overview
6.7.3 LivaNova PLC (UK) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 LivaNova PLC (UK) Veno-Arterial ECMO System Product Portfolio
6.7.5 LivaNova PLC (UK) Recent Developments/Updates
6.8 Senko Medical Instrument (Japan)
6.8.1 Senko Medical Instrument (Japan) Company Information
6.8.2 Senko Medical Instrument (Japan) Description and Business Overview
6.8.3 Senko Medical Instrument (Japan) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Senko Medical Instrument (Japan) Veno-Arterial ECMO System Product Portfolio
6.8.5 Senko Medical Instrument (Japan) Recent Developments/Updates
6.9 Johnson & Johnson MedTech (USA)
6.9.1 Johnson & Johnson MedTech (USA) Company Information
6.9.2 Johnson & Johnson MedTech (USA) Description and Business Overview
6.9.3 Johnson & Johnson MedTech (USA) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Johnson & Johnson MedTech (USA) Veno-Arterial ECMO System Product Portfolio
6.9.5 Johnson & Johnson MedTech (USA) Recent Developments/Updates
6.10 Hemovent (German)
6.10.1 Hemovent (German) Company Information
6.10.2 Hemovent (German) Description and Business Overview
6.10.3 Hemovent (German) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hemovent (German) Veno-Arterial ECMO System Product Portfolio
6.10.5 Hemovent (German) Recent Developments/Updates
6.11 Braile Biomédica (Brazil)
6.11.1 Braile Biomédica (Brazil) Company Information
6.11.2 Braile Biomédica (Brazil) Description and Business Overview
6.11.3 Braile Biomédica (Brazil) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Braile Biomédica (Brazil) Veno-Arterial ECMO System Product Portfolio
6.11.5 Braile Biomédica (Brazil) Recent Developments/Updates
6.12 Shenzhen Lifemotion Medical Technology(China)
6.12.1 Shenzhen Lifemotion Medical Technology(China) Company Information
6.12.2 Shenzhen Lifemotion Medical Technology(China) Description and Business Overview
6.12.3 Shenzhen Lifemotion Medical Technology(China) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Shenzhen Lifemotion Medical Technology(China) Veno-Arterial ECMO System Product Portfolio
6.12.5 Shenzhen Lifemotion Medical Technology(China) Recent Developments/Updates
6.13 Rocket Medical (Beijing)(China)
6.13.1 Rocket Medical (Beijing)(China) Company Information
6.13.2 Rocket Medical (Beijing)(China) Description and Business Overview
6.13.3 Rocket Medical (Beijing)(China) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Rocket Medical (Beijing)(China) Veno-Arterial ECMO System Product Portfolio
6.13.5 Rocket Medical (Beijing)(China) Recent Developments/Updates
6.14 Jiangsu STMed Technology(China)
6.14.1 Jiangsu STMed Technology(China) Company Information
6.14.2 Jiangsu STMed Technology(China) Description and Business Overview
6.14.3 Jiangsu STMed Technology(China) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Jiangsu STMed Technology(China) Veno-Arterial ECMO System Product Portfolio
6.14.5 Jiangsu STMed Technology(China) Recent Developments/Updates
6.15 Suzhou Hengrui Hongyuan Medical Technology(China)
6.15.1 Suzhou Hengrui Hongyuan Medical Technology(China) Company Information
6.15.2 Suzhou Hengrui Hongyuan Medical Technology(China) Description and Business Overview
6.15.3 Suzhou Hengrui Hongyuan Medical Technology(China) Veno-Arterial ECMO System Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Suzhou Hengrui Hongyuan Medical Technology(China) Veno-Arterial ECMO System Product Portfolio
6.15.5 Suzhou Hengrui Hongyuan Medical Technology(China) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veno-Arterial ECMO System Industry Chain Analysis
7.2 Veno-Arterial ECMO System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veno-Arterial ECMO System Production Mode & Process Analysis
7.4 Veno-Arterial ECMO System Sales and Marketing
7.4.1 Veno-Arterial ECMO System Sales Channels
7.4.2 Veno-Arterial ECMO System Distributors
7.5 Veno-Arterial ECMO System Customer Analysis
8 Veno-Arterial ECMO System Market Dynamics
8.1 Veno-Arterial ECMO System Industry Trends
8.2 Veno-Arterial ECMO System Market Drivers
8.3 Veno-Arterial ECMO System Market Challenges
8.4 Veno-Arterial ECMO System Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Veno-Arterial ECMO System market is projected to grow from US$ 278 million in 2025 to US$ 343 million by 2032, at a CAGR of 3.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-10
Pages: 170
USD 4900.00
(Single User License)
The global Veno-Arterial ECMO System market size was US$ 278 million in 2025 and is forecast to reach a readjusted size of US$ 343 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-07-10
Pages: 138
USD 4250.00
(Single User License)
The global market for Veno-Arterial ECMO System was estimated to be worth US$ 278 million in 2025 and is projected to reach US$ 343 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-07-10
Pages: 137
USD 3950.00
(Single User License)
The global Veno-Arterial ECMO System market is projected to grow from US$ 271 million in 2024 to US$ 334 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 126
USD 4900.00
(Single User License)
In 2024, the global market size of Veno-Arterial ECMO System was estimated to be worth US$ 271 million and is forecast to reach approximately US$ 334 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 118
USD 5900.00
(Single User License)
The global Veno-Arterial ECMO System market size was US$ 271 million in 2024 and is forecast to a readjusted size of US$ 334 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 70
USD 4250.00
(Single User License)
The global market for Veno-Arterial ECMO System was estimated to be worth US$ 271 million in 2024 and is forecast to a readjusted size of US$ 334 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 90
USD 3950.00
(Single User License)
The global market for Veno-Arterial ECMO System was valued at US$ 271 million in the year 2024 and is projected to reach a revised size of US$ 334 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-01-16
Pages: 83
USD 2900.00
(Single User License)
This report studies the Veno-Arterial ECMO System market. Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. Veno-Arterial ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since Veno-Arterial ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
This report studies the Veno-Arterial ECMO System market. Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. Veno-Arterial ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since Veno-Arterial ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Published Date: 2024-04-16
Pages: 131
USD 5900.00
(Single User License)
The global Veno-Arterial ECMO System market is projected to grow from US$ 278 million in 2025 to US$ 343 million by 2032, at a CAGR of 3.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-10
Pages: 170
The global Veno-Arterial ECMO System market size was US$ 278 million in 2025 and is forecast to reach a readjusted size of US$ 343 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-07-10
Pages: 138
The global market for Veno-Arterial ECMO System was estimated to be worth US$ 278 million in 2025 and is projected to reach US$ 343 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-07-10
Pages: 137
The global Veno-Arterial ECMO System market is projected to grow from US$ 271 million in 2024 to US$ 334 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 126
In 2024, the global market size of Veno-Arterial ECMO System was estimated to be worth US$ 271 million and is forecast to reach approximately US$ 334 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 118
The global Veno-Arterial ECMO System market size was US$ 271 million in 2024 and is forecast to a readjusted size of US$ 334 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 70
The global market for Veno-Arterial ECMO System was estimated to be worth US$ 271 million in 2024 and is forecast to a readjusted size of US$ 334 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 90
The global market for Veno-Arterial ECMO System was valued at US$ 271 million in the year 2024 and is projected to reach a revised size of US$ 334 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-01-16
Pages: 83
This report studies the Veno-Arterial ECMO System market. Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. Veno-Arterial ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since Veno-Arterial ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Published: 2024-04-17
Pages: 141
This report studies the Veno-Arterial ECMO System market. Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. Veno-Arterial ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since Veno-Arterial ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Published: 2024-04-16
Pages: 131
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now